GLP-1 receptor agonist use in patients with psoriasis or hidradenitis suppurativa [0.03%]
GLP-1受体激动剂在银屑病或毛囊炎患者中的使用
Rachel Granovsky,Allison Bai,Ilona Ponyatyshyn et al.
Rachel Granovsky et al.
Adults with a history of melanoma have higher odds of laryngeal cancer in the United States [0.03%]
美国黑色素瘤成人患者的喉癌患病率较高
Aya Youssef,Yeon Joo Kim,Brandon Smith et al.
Aya Youssef et al.
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP) [0.03%]
一项关于德鲁瓦卡替尼治疗中重度头皮银屑病疗效和安全性的3b/4期、多中心、随机、双盲、安慰剂对照试验（PSORIATYK SCALP研究）：第16周结果报告：一种口服的、选择性的小分子酪氨酸激酶2(TYK2)错位抑制剂
Kristina Callis Duffin,Christopher E M Griffiths,Matthias Hoffmann et al.
Kristina Callis Duffin et al.
Background: Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, is approved in multiple countries for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy. ...
Eye involvement in a series of 94 young patients with congenital ichthyosis: Importance of early ophthalmological referral [0.03%]
先天性鱼鳞病患儿的眼部受累：早期眼科转诊的重要性（94例报道）
Natalia Blanco-Calvo,Antonio Núñez-Reiz,Isabel Vals-Ferrán et al.
Natalia Blanco-Calvo et al.
Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study [0.03%]
银屑病患者亚临床动脉粥样硬化的患病率、多辖区血管分布及负担：EDSAP研究
Carlota Abbad-Jaime de Aragon,Emilio Berna-Rico,Alba Lecumberri et al.
Carlota Abbad-Jaime de Aragon et al.
Background: Psoriasis increases atherosclerosis risk due to inflammation. To date, subclinical atherosclerosis (SA) in psoriasis has only been studied in individual vascular territories by imaging. ...
Evaluation of ASCA IgA/IgG seropositivity, fecal calprotectin levels and NOD2 gene polymorphisms in patients with hidradenitis suppurativa: A prospective case-control study [0.03%]
ASCA免疫球蛋白A/免疫球蛋白G阳性、粪便Cal保护蛋白水平和NOD2基因多态性在汗腺炎患者中的评估：一项前瞻性病例对照研究
Mahmut Esat Tanrıbilir,Ahmet Burhan Aksakal,Özlem Gülbahar et al.
Mahmut Esat Tanrıbilir et al.
Chenan A Huang,Anna K Martino,Emily E Antalika et al.
Chenan A Huang et al.
Efficacy and safety of CBL-514 for Dercum disease lipomas: A randomized phase 2a study [0.03%]
CBL-514治疗德库姆病脂肪瘤的疗效和安全性：一项随机IIa期研究
Karen Louise Herbst,Yu-Fang Ling,An-Yi Sheu et al.
Karen Louise Herbst et al.
Joong Heon Suh,Jungyoon Ohn,Keunyoung Hur et al.
Joong Heon Suh et al.